p53 Mutations and Expression in Breast Carcinoma in Situ
- 1 January 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (1) , 183-191
- https://doi.org/10.1016/s0002-9440(10)64718-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breastEuropean Journal Of Cancer, 1996
- TP53 alterations in atypical ductal hyperplasia and ductal carcinomain situ of the breastBreast Cancer Research and Treatment, 1996
- Refined solution structure of the oligomerization domain of the tumour suppressor p53Nature Structural & Molecular Biology, 1995
- How loops, β sheets, and α helices help us to understand p53Cell, 1994
- High-Resolution Structure of the Oligomerization Domain of p53 by Multidimensional NMRScience, 1994
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated regionCell, 1993
- p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic GradeJapanese Journal of Cancer Research, 1993
- Biomarkers in early breast neoplasiaJournal of Cellular Biochemistry, 1993